181 related articles for article (PubMed ID: 16425978)
1. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
Matsui T; Yamagishi S; Nakamura K; Kikuchi S; Inoue H
Drugs Exp Clin Res; 2005; 31(5-6):215-9. PubMed ID: 16425978
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
Yamagishi S; Matsui T; Nakamura K; Inoue H
Int J Tissue React; 2005; 27(4):197-202. PubMed ID: 16440585
[TBL] [Abstract][Full Text] [Related]
4. Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Shimizu K; Takegami Y; Shimizu T; Inoue H; Imaizumi T
Microvasc Res; 2006 May; 71(3):222-6. PubMed ID: 16624340
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.
Yamagishi S; Matsui T; Inoue H
Drugs Exp Clin Res; 2005; 31(5-6):227-32. PubMed ID: 16425980
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
[TBL] [Abstract][Full Text] [Related]
7. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
Nakamura K; Yamagishi S; Inoue H
Med Hypotheses; 2005; 65(1):155-7. PubMed ID: 15893134
[TBL] [Abstract][Full Text] [Related]
8. Antioxidative effects of azelnidipine on mesangial cell proliferation induced by highly concentrated insulin.
Manabe S; Okura T; Fukuoka T; Higaki J
Eur J Pharmacol; 2007 Jul; 567(3):252-7. PubMed ID: 17544393
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.
Yamagishi S; Inagaki Y; Nakamura K; Abe R; Shimizu T; Yoshimura A; Imaizumi T
J Mol Cell Cardiol; 2004 Aug; 37(2):497-506. PubMed ID: 15276019
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
12. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
13. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-type 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation.
Yamagishi S; Amano S; Inagaki Y; Okamoto T; Inoue H; Takeuchi M; Choei H; Sasaki N; Kikuchi S
Drugs Exp Clin Res; 2003; 29(2):75-80. PubMed ID: 12951837
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells.
Yoshimoto T; Gochou N; Fukai N; Sugiyama T; Shichiri M; Hirata Y
Hypertens Res; 2005 Feb; 28(2):165-72. PubMed ID: 16025744
[TBL] [Abstract][Full Text] [Related]
16. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity.
Kimura Y; Hirooka Y; Sagara Y; Sunagawa K
Clin Exp Hypertens; 2007 Jan; 29(1):13-21. PubMed ID: 17190727
[TBL] [Abstract][Full Text] [Related]
17. A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates.
Nakano K; Egashira K; Tada H; Kohjimoto Y; Hirouchi Y; Kitajima S; Endo Y; Li XH; Sunagawa K
J Hypertens; 2006 Sep; 24(9):1881-9. PubMed ID: 16915039
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine inhibits tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation.
Yamagishi S; Inagaki Y; Kikuchi S
Drugs Exp Clin Res; 2003; 29(4):147-52. PubMed ID: 15018305
[TBL] [Abstract][Full Text] [Related]
19. Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells.
Li JM; Iwai M; Cui TX; Min LJ; Tsuda M; Iwanami J; Suzuki J; Mogi M; Horiuchi M
Mol Pharmacol; 2005 May; 67(5):1666-73. PubMed ID: 15695623
[TBL] [Abstract][Full Text] [Related]
20. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
